martes, 3 de octubre de 2017

31st ANNUAL CONGRESS AMERICAN COLLEGE OF PHLEBOLOGY. NOVEMBER 2 - 5, 2017. AUSTIN, TX.


2 comentarios:

  1. Shame. Still profitable “technological advances” at the service of “retrograde pathophysiologic concepts” . Though the “advanced haemodynamics concepts” are demonstrated by RCTs and Cochrane review as superior in terms of therapeutic outcomes and patient sake, they are not welcome into symposiums and congresses. The reason is intellectual laziness of the to many colleagues combined with the less expensive consequent treatments sadly not profitable to sponsors. Who will finally drive away the merchants from the congresses and symposiums and let enter oxygen for the doctor’s brain and the best for the patient sake in terms of more efficient venous insufficiency treatments and Saphena saving for future arterial by-pass?

    ResponderEliminar
    Respuestas
    1. Dear colleague, your opinion is very respectable. Best regards.

      Eliminar